OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,274,344 | -45.1% | 1,361,256 | -9.8% | 0.00% | 0.0% |
| Q2 2023 | $7,789,799 | -25.2% | 1,509,651 | -23.6% | 0.00% | -50.0% |
| Q1 2023 | $10,408,630 | +79.0% | 1,975,072 | -4.6% | 0.00% | +100.0% |
| Q4 2022 | $5,815,958 | -6.0% | 2,069,736 | +38.8% | 0.00% | 0.0% |
| Q3 2022 | $6,189,000 | -11.4% | 1,491,025 | -14.2% | 0.00% | -50.0% |
| Q2 2022 | $6,982,000 | -18.0% | 1,736,893 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $8,512,000 | -26.6% | 1,719,636 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $11,596,000 | +222.8% | 1,663,722 | +363.2% | 0.00% | +100.0% |
| Q3 2021 | $3,592,000 | -36.4% | 359,205 | -9.8% | 0.00% | 0.0% |
| Q2 2021 | $5,644,000 | +59.5% | 398,050 | +84.6% | 0.00% | – |
| Q1 2021 | $3,538,000 | -89.9% | 215,581 | -87.2% | 0.00% | -100.0% |
| Q4 2020 | $34,966,000 | +173.6% | 1,689,174 | +0.6% | 0.01% | +125.0% |
| Q3 2020 | $12,781,000 | +441.1% | 1,679,463 | +492.5% | 0.00% | +300.0% |
| Q2 2020 | $2,362,000 | +322.5% | 283,469 | +151.0% | 0.00% | – |
| Q1 2020 | $559,000 | +134.9% | 112,937 | +87.5% | 0.00% | – |
| Q4 2019 | $238,000 | +19.6% | 60,227 | -8.1% | 0.00% | – |
| Q3 2019 | $199,000 | -31.8% | 65,554 | -1.2% | 0.00% | – |
| Q2 2019 | $292,000 | -2.7% | 66,320 | -12.2% | 0.00% | – |
| Q1 2019 | $300,000 | -9.6% | 75,504 | -9.4% | 0.00% | – |
| Q4 2018 | $332,000 | -32.8% | 83,306 | +16.1% | 0.00% | – |
| Q3 2018 | $494,000 | +69.2% | 71,766 | +66.0% | 0.00% | – |
| Q2 2018 | $292,000 | +126.4% | 43,236 | +118.4% | 0.00% | – |
| Q1 2018 | $129,000 | +27.7% | 19,800 | -12.0% | 0.00% | – |
| Q4 2017 | $101,000 | -34.0% | 22,489 | -9.0% | 0.00% | – |
| Q3 2017 | $153,000 | -68.7% | 24,700 | -53.1% | 0.00% | – |
| Q2 2017 | $489,000 | +35.5% | 52,700 | +35.5% | 0.00% | – |
| Q1 2017 | $361,000 | +113.6% | 38,900 | +92.6% | 0.00% | – |
| Q4 2016 | $169,000 | +131.5% | 20,200 | +90.6% | 0.00% | – |
| Q3 2016 | $73,000 | -74.5% | 10,600 | -81.7% | 0.00% | – |
| Q2 2016 | $286,000 | +221.3% | 57,791 | +505.6% | 0.00% | – |
| Q4 2015 | $89,000 | -76.1% | 9,542 | -46.0% | 0.00% | – |
| Q2 2015 | $372,000 | – | 17,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |